Round Includes Strong Participation from Regional Investors Including 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Cristiano Ronaldo and Karen Wazen, Highlighting the GCC as a Key Strategic Growth Market
WHOOP, the human performance company, today announced it has raised $575 million in Series G funding at a $10.1 billion valuation, advancing its global expansion and long-term vision for personalized health. The round was led by Collaborative Fund and includes strong participation from GCC-based investors, including 2PointZero Group, Qatar Investment Authority (QIA), and Mubadala Investment Company, alongside global investors Abbott, the Mayo Clinic, Macquarie Capital (entities administered by Macquarie Capital), Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners and Bullhound Capital, as well as prominent global athletes and individual investors.
Individual investors in the round include notable figures with strong ties to the GCC, including Cristiano Ronaldo and Karen Wazen. Other individuals investing in the round include LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Virgil van Dijk, and Shane Lowry, underscoring the brand’s growing cultural relevance across the region and deep connection to elite performance, health and global culture.
This funding comes at a defining moment for WHOOP and the future of health. Chronic disease is rising globally, while many healthcare systems remain built for reactive care. At the same time, advances in AI and continuous biometric data are enabling a fundamentally new approach that predicts risk, guides behavior, and improves health in real time. WHOOP has spent over a decade building toward this moment. With this investment, the company will accelerate global expansion and scale its platform as a new standard for personalized, preventive health.
“We are building the personal health platform that people use to improve their health and livelihood,” said Will Ahmed, Founder and CEO of WHOOP. “The GCC is one of the most forward-looking regions in the world when it comes to health, performance and longevity. We’re building real momentum on the ground, expanding our local teams and growing our retail footprint in multiple markets. We’re also developing meaningful partnerships across the region to integrate WHOOP into broader health and performance ecosystems. We’re committed to investing here for the long term. We’re especially proud to be joined by so many investors from the region.”
Accelerating International Growth
WHOOP is experiencing rapid global momentum amid an extraordinary period of growth:
- The company now has over 2.5 million members around the world
- In 2025, bookings grew 103% year-over-year, exiting the year at a $1.1B run rate
- In 2025, WHOOP operated cash flow positive
- WHOOP is hiring for over 600 new roles around the world this year to support research and development and international expansion
Proceeds from this Series G financing will fuel international expansion across the GCC, Europe, Latin America, and Asia.
Building the Preeminent Global Health Platform
This financing will accelerate WHOOP in building the world’s leading personal health platform – an intelligent, unified system designed to extend healthspan, optimize performance, and prevent disease before it begins.
As part of its international expansion, WHOOP is scaling its presence across the GCC to deepen research and innovation capabilities while contributing to the region’s rapidly evolving performance science ecosystem. In the coming months, WHOOP will open WHOOP Labs Doha, the company’s first international performance research and development facility, marking a significant milestone in its global growth. Alongside this, WHOOP is advancing a series of initiatives across the UAE and Qatar designed to accelerate adoption and establish WHOOP as a leader in health and human performance across the region.
Powered by more than 24 billion hours of physiological data and purpose-built AI models, WHOOP delivers predictive, personalized health insights. Members open the app an average of over eight times per day – almost three times higher than other screenless wearables – to understand how they slept, whether they are recovered, how hard to push or pull back, and how daily behaviors like training, nutrition, and stress are impacting their performance and long-term health. These insights go beyond sleep and fitness, helping members identify early warning signs, reduce risk, and take action that can prevent serious health events. From world leaders and executives to elite athletes and artists, WHOOP has become an essential platform for those committed to performing and living at their highest level.
“WHOOP has become one of the most important tools I use to support my long-term health,” said Cristiano Ronaldo, a WHOOP investor and global ambassador. “I am proud to participate in this round because I believe in the future we are building together. No other company has created a health platform this powerful that people are proud to wear.”
About WHOOP
WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.
Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 56 countries, and operates in six languages.
